CVS sued by NY state over expired drugs
The US state of New York is suing the USA's second largest drug store chain by outlet numbers, CVS Caremark, over the sale of expired products, including pharmaceuticals. On the day of the announcement, December 4, the authorities also reported the settlement of a $1.3-million claim against the third-ranked Rite Aid drug stores for similar alleged violations.
A report in the Providence Journal claimed "items that had expired as far back as 2006" were involved in the CVS case. Investigators allegedly discovered goods which exceeded the sell-by date in 60% of the chain's branches in New York state. The biggest pharmacy chain is Walgreen.
Michael DeAngelis, a CVS spokesman, told the Providence Journal that "we have a specific product-removal policy. Over the last several months we retained our employees to ensure compliance."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze